Tuebingen, Germany and Houston, Texas, September 15, 2020 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in […]
$2.5 billion in originations volume in August, nearly double June volumeContinued momentum in operating and financial performanceWEST PALM BEACH, Fla., […]
Mainz, Germany, Sept. 15, 2020 (GLOBE NEWSWIRE) —The German Federal Ministry of Education and Research (BMBF) COVID-19 initiative supports accelerated […]